Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association
Cusi K, Abdelmalek MF, Apovian CM, et al.
Diabetes Care. 2025:dci240094.
Leggi